Cyclic hexapeptide somatostatin analogs

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2601125S, A61K 3700, C07C10352

Patent

active

044864159

ABSTRACT:
Somatostatin analogs are prepared wherein a cyclic hexapeptide contains a secondary amino acid which replaces seven of the ring amino acids of somatostatin. The cyclic hexapeptides are easier to synthesize, have a longer duration of activity, and many have a greater level of activity than somatostatin. The compounds have the properties of inhibiting the release of glucagon, growth hormone and insulin. Certain of the compounds also are capable of inhibiting gastric acid secretions. The compounds are particularly useful in the treatment of acromegaly, diabetes, diabetic retinopathy and peptic ulcers. These cyclic hexapeptides are prepared by the solid phase method.

REFERENCES:
patent: 4235886 (1980-11-01), Freidinger et al.
patent: 4310518 (1982-01-01), Freidinger et al.
Freidinger et al., Peptides: Structure and Function-Proceedings of the Eighth American Peptide Symposium edited by V. J. Hruby and D. H. Rich, pp. 349-352 (1983).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclic hexapeptide somatostatin analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic hexapeptide somatostatin analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic hexapeptide somatostatin analogs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1581923

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.